Peptides, Proteins and Biologics
Microneedle feasibility depends on target dose, molecular stability, formulation compatibility, delivery efficiency and the intended product pathway.
Application-led evaluation for microneedle product development
Microneedle feasibility depends on target dose, molecular stability, formulation compatibility, delivery efficiency and the intended product pathway.
Intradermal delivery programs require application-specific assessment of antigen stability, loading strategy, delivery performance and manufacturing controls.
Programs involving peptide payloads require careful review of dose capacity, stability, release profile and the practical patch design.
Localized delivery concepts are assessed against target tissue, intended use, active ingredient properties and regulatory classification.
Sustained-release approaches may involve layered structures, microparticles or implantable microneedle designs and require integrated formulation and process evaluation.
Send your target product, payload, development stage and cooperation scope to our business development team.
Start a Project